HTG Molecular Diagnostics and Firalis Announce an Agreement Enabling Firalis’ Commercialization of Theranostic and Research Products and Services Based on HTG EdgeSeq Technology

$HTGM HTG Molecular Diagnostics, Inc. (HTGM) (“HTG”), a provider of instruments, reagents and services for molecular profiling applications, and Firalis S.A. (“Firalis”), a provider of bioanalytical services and biomarker-based products and services, today announced a non‑exclusive license and supply agreement (“Agreement”) that will enable Firalis to commercialize a next‑generation sequencing (NGS)‑based theranostic product and services to predict rheumatoid arthritis (RA) patients response to anti‑TNFα therapy, and other research products and services for mRNA profiling of inflammatory‑autoimmune disorders. The Agreement is a next step in the parties’ relationship following the successful adaptation of Firalis’ BIOPRED* research‑use assay to HTG EdgeSeq technology.https://finance.yahoo.com/news/htg-molecul...

Read more

Recommended & Related Posts

Edited Transcript of HTGM earnings conference call or presentation 12-Nov-19 9:30pm GMT

$HTGM Q3 2019 HTG Molecular Diagnostics Inc Earnings Callhttps://finance.yahoo.com/news/edited-tran...

Read more
HTG Molecular Diagnostics to Host Key Opinion Leader Meeting on the Future of Precision Medicine

$HTGM HTG Molecular Diagnostics, Inc. (HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that it will host a Key Opinion Leader (KOL) luncheon at 12:00 pm ET on Friday, December 13th in Boston, Massachusetts. The event will feature a presentation by Laura E. Benjamin, Ph.D., Founder and CEO, Oncologie, LTD, who will discuss the future of precision medicine and its potential to bring innovative new medicines to cancer patients globally. Oncologie and HTG are partnering on the development of biomarkers associated with Oncologie’s immuno-oncology pipeline.https://finance.yahoo.com/news/htg-molecul...

Read more
Edited Transcript of HTGM earnings conference call or presentation 12-Nov-19 9:30pm GMT

$HTGM Q3 2019 HTG Molecular Diagnostics Inc Earnings Callhttps://finance.yahoo.com/news/edited-tran...

Read more
HTG Molecular Diagnostics Expands Analytics Capabilities with Release of New Software Update

$HTGM HTG Molecular Diagnostics, Inc. (HTGM) (HTG), a life science company whose mission is to advance precision medicine, yesterday announced the release of its HTG EdgeSeq Reveal data analysis software, version 2.0.0. HTG EdgeSeq Reveal is a powerful software product that streamlines sample analysis using the HTG EdgeSeq platform. The new software contains enhanced functionality enabling rapid data analysis from the HTG EdgeSeq miRNA Whole Transcriptome Assay and the newly released HTG EdgeSeq Autoimmune Panel.https://finance.yahoo.com/news/htg-molecul...

Read more
Health Check: How Prudently Does HTG Molecular Diagnostics (NASDAQ:HTGM) Use Debt?

$HTGM The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...https://finance.yahoo.com/news/health-chec...

Read more
About Contact Privacy Terms Widgets Store

There are more for you ...

View more and participate in our discussion now. It's FREE.

Creating an account means you’re okay with InvestingNote's Terms and Conditions